These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2173602)

  • 1. Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.
    Mak IT; Freedman AM; Dickens BF; Weglicki WB
    Biochem Pharmacol; 1990 Nov; 40(9):2169-75. PubMed ID: 2173602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative free radical scavenging action of angiotensin-converting enzyme inhibitors with and without the sulfhydryl radical.
    Suzuki S; Sato H; Shimada H; Takashima N; Arakawa M
    Pharmacology; 1993 Jul; 47(1):61-5. PubMed ID: 8393194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfhydryl group in angiotensin converting enzyme inhibitors and superoxide radical formation.
    Mehta JL; Nicolini FA; Lawson DL
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):847-9. PubMed ID: 1703610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-limiting enhancement by nitric oxide of oxygen free radical-induced endothelial cell injury: evidence against the dual action of NO as hydroxyl radical donor/scavenger.
    Az-ma T; Fujii K; Yuge O
    Br J Pharmacol; 1996 Oct; 119(3):455-62. PubMed ID: 8894164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors.
    Chopra M; Beswick H; Clapperton M; Dargie HJ; Smith WE; McMurray J
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):330-40. PubMed ID: 1378110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of myocardial reperfusion injury by sulfhydryl-containing angiotensin converting enzyme inhibitors.
    Liu X; Engelman RM; Rousou JA; Cordis GA; Das DK
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):437-43. PubMed ID: 1387799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril and ramiprilat protect against free radical injury in isolated working rat hearts.
    Pi XJ; Chen X
    J Mol Cell Cardiol; 1989 Dec; 21(12):1261-71. PubMed ID: 2698963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radical scavenging: a potentially beneficial action of thiol-containing angiotensin converting enzyme inhibitors.
    Chopra M; McMurray J; Stewart J; Dargie HJ; Smith WE
    Biochem Soc Trans; 1990 Dec; 18(6):1184-5. PubMed ID: 2088853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of angiotensin converting enzyme inhibitors with and without the SH-radical.
    Nakagawa M; Kobayashi K; Sawada S; Toyoda T; Shirai K; Katoh K; Yamamoto K; Tsuji H; Sasaki S; Takeda K
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):54S-55S. PubMed ID: 1848988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of .OH scavenging action by non-SH-containing angiotensin converting enzyme inhibitor imidaprilat using microdialysis.
    Obata T; Yamanaka Y
    J Physiol Paris; 1998 Feb; 92(1):1-4. PubMed ID: 9638590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers.
    Mira ML; Silva MM; Queiroz MJ; Manso CF
    Free Radic Res Commun; 1993; 19(3):173-81. PubMed ID: 8244086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free radical scavenging properties of alacepril metabolites and lisinopril.
    Noda Y; Mori A; Packer L
    Res Commun Mol Pathol Pharmacol; 1997 May; 96(2):125-36. PubMed ID: 9226747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of zofenopril and lisinopril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE-inhibitors in experimental heart failure.
    Buikema H; Monnink SH; Tio RA; Crijns HJ; de Zeeuw D; van Gilst WH
    Br J Pharmacol; 2000 Aug; 130(8):1999-2007. PubMed ID: 10952693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KATP channel opening does not contribute significantly to the vasodilatory effect of SH-group-containing ACE inhibitors.
    Köppel H; Holzmann S; Klein W; Horn E; Horn S; Gasser R
    Heart Vessels; 1996; 11(4):192-6. PubMed ID: 9119808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
    Westlin W; Mullane K
    Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin-mediated protection by angiotensin-converting enzyme inhibitors against injury of aortic endothelium by free radicals.
    Liao DF; Chen X
    Cardioscience; 1992 Jun; 3(2):79-84. PubMed ID: 1379480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.
    Mittra S; Singh M
    Mol Cell Biochem; 1998 Jun; 183(1-2):63-7. PubMed ID: 9655179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress.
    Scribner AW; Loscalzo J; Napoli C
    Eur J Pharmacol; 2003 Dec; 482(1-3):95-9. PubMed ID: 14660009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells.
    Yue TL; Mckenna PJ; Gu JL; Cheng HY; Ruffolo RR; Feuerstein GZ
    Hypertension; 1993 Dec; 22(6):922-8. PubMed ID: 7902335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of endothelial cell free radical generation: evidence for a central mechanism of free radical injury in postischemic tissues.
    Zweier JL; Kuppusamy P; Lutty GA
    Proc Natl Acad Sci U S A; 1988 Jun; 85(11):4046-50. PubMed ID: 2836868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.